Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CeriBell, Inc. (CBLL : NSDQ)

• Company Description    CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs of patients in the acute care setting. CeriBell Inc. is based in Sunnyvale, Calif. Number of Employees: 327

• Price / Volume Information    Yesterday's Closing Price: $16.46 Daily Weekly Monthly 20 Day Moving Average: 324,235 shares Shares Outstanding: 37.94 (millions) Market Capitalization: $624.54 (millions) Beta: 0.99 52 Week High: $24.33 52 Week Low: $10.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -20.64% -25.50% 12 Week -18.92% -25.83% Year To Date -24.94% -31.50%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 360 N. PASTORIA AVENUE - SUNNYVALE,CA 94085 USA ph: 800-436-0826 fax: - investors@ceribell.com https://ceribell.com

• General Corporate Information    Officers Xingjuan (Jane) Chao - President; Chief Executive Officer; and Director Rebecca Robertson - Chair of the Board of Directors Scott Blumberg - Chief Financial Officer David Foehr - Senior Vice President; Finance Juliet Tammenoms Bakker - Director Peer Information CeriBell, Inc. (BJCT) CeriBell, Inc. (CADMQ) CeriBell, Inc. (APNO) CeriBell, Inc. (UPDC) CeriBell, Inc. (IMTIQ) CeriBell, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 15678C102 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 37.94 Most Recent Split Date: (:1) Beta: 0.99 Market Capitalization: $624.54 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.48 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.67 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 25.90% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.43 Price/Cash Flow: - Price / Sales: 6.57 EPS Growth vs. Year Ago Period: -44.44% vs. Previous Quarter: -44.44% Sales Growth vs. Year Ago Period: 29.30% vs. Previous Quarter: 6.90% ROE 03/31/26 - -38.19 12/31/25 - -31.77 09/30/25 - -29.63 ROA 03/31/26 - -30.92 12/31/25 - -26.17 09/30/25 - -24.80 Current Ratio 03/31/26 - 10.44 12/31/25 - 9.73 09/30/25 - 12.65 Quick Ratio 03/31/26 - - 12/31/25 - 9.35 09/30/25 - 12.25 Operating Margin 03/31/26 - -63.51 12/31/25 - -59.97 09/30/25 - -63.35 Net Margin 03/31/26 - -63.51 12/31/25 - -59.97 09/30/25 - -63.35 Pre-Tax Margin 03/31/26 - -63.51 12/31/25 - -59.97 09/30/25 - -63.35 Book Value 03/31/26 - 3.71 12/31/25 - 4.19 09/30/25 - 4.48 Inventory Turnover 03/31/26 - 1.78 12/31/25 - 1.67 09/30/25 - 1.56 Debt-to-Equity 03/31/26 - 0.14 12/31/25 - 0.13 09/30/25 - 0.12 Debt-to-Capital 03/31/26 - 12.39 12/31/25 - 11.31 09/30/25 - 10.74

Powered by Zacks Investment Research ©